Ann: BIT225 Effectiveness Against COVID-19 in Animals, page-48

I think it was good that BIT released this update and any positive news on a companies product is worth celebrating. It is not the end gam at the moment though.

Just remember that the update supports the "effectiveness" of BIT225 - and so far, in animal trials.

keep in mind that there are only two success parameters with biotechs.

1: They have a unique product that is the only one that works.
2: or they have a product that is better than their competitors.

Hopefully, BIT will get there soon and maybe get partners to fund a human trial tha has great results that re better than the competition.